"Tomorrow's Technology Today" about SIMpill:
 | |  | |  |
greater impact on the health of the population than any improvement in
specific medical treatments."
- World Health Organization 2003 - Non-communicable Diseases
and Mental Health Adherence to Long-term Therapies Project
Our Goal
Good patient compliance and adherence means taking the right drugs, on time and in the proper doses. Today, as
medication adherence continues to gather news headlines with surprising stories of the perils and pitfalls of treatment non-
compliance, Clinical Technology Advisors, Inc (CTA) will position itself as the leading provider of innovative medication
adherence technology solutions for the consumer health care market. We will improve lives through medication
adherence and patient compliance.
Key Management
David Rosa is the Founder and President of CTA.
Mr. Rosa maintains his responsibilities for corporate governance and vision, managing the current consulting practice, and working to grow
alliances with other companies that will further enhance the value of the Simpill partnership and CTA in general.
Mr. Rosa has worked within the biopharmaceutical industry for nearly 20 years. He has a M.S. in biostatistics from the University of
Massachusetts at Amherst School of Public Health and initially worked as a project manager and statistician for Consulting Statisticians, Inc.,
who was acquired by PAREXEL. While part of PAREXEL, Mr. Rosa moved from his statistical role into the business development arena
where he was responsible for managing large pharmaceutical accounts and some emerging biotechnology companies. After leaving
PAREXEL, Mr. Rosa held various positions at Vertex Pharmaceuticals, InSite Clinical Trials, and MTRA (now aaiPharma).
In late 1997, Mr. Rosa was asked by Dr. Paul Bleicher (a former PAREXEL colleague) to join his start-up company, Phase Forward, Inc.
Mr. Rosa assumed the role of Sales and Marketing Director and was responsible for launching their InForm electronic data capture product,
overseeing the marketing responsibilities of the product and generating the initial sales of the product to the first customers. He then became a
Sales Director for the major accounts using the InForm product.
In June of 2000, Mr. Rosa joined Invivodata, Inc., a leader in the field of electronic patient diaries. As Vice President of Sales, Mr. Rosa
drove the initial sales of the organization and helped to promote the capture of patient self-report data using handheld (Palm) technology. He
also opened the international market for Invivodata by winning their initial global projects.
In 2005 he founded Clinical Technology Advisors, where Mr. Rosa's commitment is to improve lives through medication adherence.
Paul Molinari is Vice President of Marketing and Operations.
He is responsible for the marketing and promotion of CTA and its products and services. He is also responsible for developing the consumer
market for SIMpill.
From 1999 to late 2005 Mr. Molinari was the Manager of Strategic Alliances and Licensing at Thomson CenterWatch, a Boston-based
publishing and media company that focuses on the clinical trial industry. CenterWatch.com is the world’s most successful clinical trials
website for patients and industry professionals. By building innovative strategic alliances with companies such as Abbott Laboratories, Roche
Pharmaceuticals, Discovery Health Channel, Yahoo! Health, and WebMD.com, Mr. Molinari helped CenterWatch build and sustain one of
the most respected brand names in the clinical trials industry.
Mr. Molinari also had a successful career in the consumer electronics industry, where from 1994 to 1998 he headed the marketing efforts for
Terk Technologies (now a division of Audiovox), a well-known NY-based manufacturer of wireless and RF accessory products. Through
inventive point-of-purchase marketing programs, Mr. Molinari was able to help Terk achieve national brand exposure with retailers such as
Best Buy, Circuit City, Tweeter, and Radio Shack.
Mr. Molinari received a BS in Business Administration from Marist College in Poughkeepsie, NY and his MBA from Northeastern
University in Boston, MA. At Northeastern University he concentrated his studies in marketing and supply chain management.
Advisory Board
Dr. Michael Singer serves as a clinician and researcher at Harvard University.
After an M.D. and Ph.D. at Yale University, he trained clinically at Harvard Medical School. While at Yale, he studied medical informatics
with the support of an NIH fellowship. The work led has led to over 30 publications on biomedical pattern analysis, on diverse topics from
protein structure to motor vehicle collisions. To build on his interests in medication adherence and preventive medicine, Dr. Singer has
invented a number of new medical devices and analysis methods, particularly in the pulmonary space. He is currently a co-leader on a
Harvard-funded initiative to use wireless networks to predict and prevent asthma attacks.
Dr. Singer serves as a consultant to medical device manufacturers, pharmaceutical companies, and health ministries in other countries. He
has carried out considerable work in low-income countries, with an emphasis on Latin America, the Middle East, and the Indian subcontinent.
He is a member of the Senior Common Room at Harvard's Eliot House, where he is chairman of the premedical committee.
Brian K. Perry, is President and Chief Executive Officer at BKP Technologies, Inc. of Newton, MA. He is responsible for the daily
operation and direction of the company and for providing consulting services to clients in the areas of: Application Design/Development;
Information Systems Strategies; and Vertical Application implementation. Prior to starting the company in 2001, Mr. Perry was an
independent consultant and was the former President and CEO of Versal Technologies, Inc. of Boston, MA where he grew the company
from a staff of two to a staff of twelve delivering IT solutions to major pharmaceutical clients around the world. Prior to starting Versal in 1995,
Mr. Perry was the Director of Information Systems at Vertex Pharmaceuticals Incorporated of Cambridge, MA. He was also a Systems
Engineer with IBM Corporation. Mr. Perry holds a Bachelor of Science in Computer Science, magna cum laude, from Northeastern
University.
Stuart Woodring’s professional experience over the last 20 years has focused on analyzing the growth and opportunities in technology
markets. Throughout his career, he has led high-impact market analyses, managed very talented knowledge workers in a high-growth
environment, worked as a member of an executive team to complete a very successful IPO, conducted independent consulting
engagements, and participated in venture capital activities.
In 2002, Mr. Woodring completed a successful 12-year career with Forrester Research, one of the leading technology research companies.
During his time with Forrester, Mr. Woodring was instrumental in the growth the company's research organization and started numerous new
research activities. He served on the company’s executive team, worked to prepare the company for its IPO, managed the entire US
research organization, and championed the company’s international expansion. During Mr. Woodring’s employment with Forrester, the
company grew from less than 10 employees to over 750. At its peak, Forrester had a market capitalization of over $1 billion.
Prior to joining Forrester Research, Mr. Woodring was an independent marketing and strategy consultant to the computer, communications,
and telecommunications industries. His earlier business experience includes corporate finance work with Bank Boston (now part of Bank of
America) and management consulting with Bain & Co., a leading strategy consulting firm.
Mr. Woodring is a Phi Beta Kappa graduate of Dartmouth College, with degrees in both engineering sciences and economics. Additionally,
Mr. Woodring has participated in executive education programs at Harvard Business School, Columbia Business School, and the Center for
Creative Leadership.
Pharmacists, and Home
Care Professionals.
click here
Copyright © 2006 Clinical Technology Advisors, Inc. All Rights Reserved. Simpill is a registered trademark of Simpill (Pty.) Ltd. All Rights Reserved.
